* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Powerful Vaccine Discovery
Thiomersal controversy wikipedia , lookup
Vaccination policy wikipedia , lookup
Globalization and disease wikipedia , lookup
DNA vaccination wikipedia , lookup
Orthohantavirus wikipedia , lookup
Cysticercosis wikipedia , lookup
Herd immunity wikipedia , lookup
Whooping cough wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Non-specific effect of vaccines wikipedia , lookup
HIV vaccine wikipedia , lookup
Vaccine Discovery Licensing Technology Powerful Vaccine Discovery Therapeutic vaccines have the potential to reach large populations and prevent endemic disease. Using novel technologies such as flagellin-based fusion proteins, scientists at Wake Forest Baptist Medical Center and Wake Forest University are developing highly potent, cost-effective vaccines that provide protective immunity against a range of illnesses. These new vaccine technologies are available for licensing and further development by industry partners and investment organizations: Pneumonic Plague Vaccine Vaccine Against Pneumococcus This vaccine uses a fusion protein that comprises flagellin and the F1- and V-antigens of Yersinia pestis, resulting in powerful immunity against pneumonic plague. It has significant potential to be the first approved vaccine for pneumonic plague. (Ref # WFU 05-13) This vaccine uses a fusion protein of flagellin and various pspA antigens to provide protection against multiple disease-causing pneumococcal serotypes. (Ref # WFU 09-50) Pseudomonas Aeruginosa Vaccine This vaccine produces a robust immune response to Pseudomonas aeruginosa, a major cause of morbidity and mortality in cystic fibrosis and ventilated patients, using a fusion protein of flagellin and the OprI and OprF antigens. (Ref # WFU 09-14) Vaccine against Drugs of Abuse Vaccine therapies comprised of a drug-flagellin conjugate are in development to promote long-lasting, high level of immunity to drugs of abuse. (Ref # WFU 09-56) Breast Cancer Vaccine This vaccine, which selectively targets breast cancer cells, consists of a fusion protein of flagellin and the Fra-1 antigen. (Ref # 05-13) Vaccine for Bordetella Bronchisepticamediated Respiratory Infections This acellular Bordetella bronchiseptica vaccine is comprised of the immunogenic BcfA (Bordetella colonization factor A) protein, which establishes protective immunity in vivo against Bordetella infections without the risk of subsequent infection by the vaccine strain and disease. (Ref # WFU 08-11) About Wake Forest Innovations Wake Forest Innovations commercializes technology, products and services arising from the discoveries and scientific assets of Wake Forest Baptist Medical Center and Wake Forest University. The enterprise facilitates innovation and partners our proprietary technology; enables other organizations and companies to access our scientific assets; and develops the Innovation Quarter as a locale for creative innovation in biomedicine and information technology. Wake Forest Innovations Wake Forest Biotech Place 575 N. Patterson Ave., Suite 550 Winston-Salem, NC 27101 WakeForestInnovations.com [email protected] +1.336.716.8508